Business
Società Chimica Bussi investing in capacity
Società Chimica Bussi investing in capacity.

About this update from Itaconix Plc
[{"type":"text","content":"\n \nRNS Number : 6632T Itaconix PLC 16 October 2017 \n\n16 October 2017\nItaconix plc (\"Itaconix\")\n Società Chimica Bussi investing in additional manufacturing capacity for EurecoTM RP103 granules developed by Itaconix\n \nItaconix, a leading innovator in sustainable performance polymers, is pleased to announce that Società Chimica Bussi S.p.A. (\"SCB\") has decided to invest in facilities for the production of the new granular grade EurecoTM RP103 (\"RP103\"), a product developed by Itaconix and licensed to Solvay SA (\"Solvay\"). Solvay sold its Bussi site to SCB in 2016, including the manufacturing facility for RP103, but maintains its role of exclusive distributor of EurecoTM products worldwide, except in Italy.\nSCB has already started a series of investments on the site to ensure its sustainability and growth, as well as creating synergies with its current portfolio of activities. Building on the actions initiated by Solvay and as a result of growing commercial interest, SCB has decided to support the availability of EurecoTM products in granular form and has prioritised the investment at the Bussi plant in Italy.\n \nRP103, is based on 6-phthalimido-peroxyhexanoic acid (PAP), which is already well-known among the consumer and professional detergents markets for its effectiveness in removing stubborn stains, bleaching in compact product formulations, and the elimination of malodour, germs, bacteria and fungi on both textiles and hard surfaces.\n \nThis announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.\nEnds\nFor further information please contact: \n\n\n\n\nItaconix \n\n\n+44 (0) 1244 283 500\n\n\n\n\nKevin Matthews / Rob Cridland \n \n\n\n\n\n\n\n\nN+1 Singer\n\n\n+44 (0) 207 496 3000\n\n\n\n\nRichard Lindley / Liz Yong (Corporate Finance) \nNick Owen (Corporate Broking)\n \n\n\n\n\n\n\n\nHudson Sandler\n\n\n+44 (0) 207 796 4133\n\n\n\n\nCharlie Jack / Emily Dillon\n\n\n\n\n\n\n\n \nAbout Itaconix\nItaconix designs and manufactures high performance, cost effective and sustainable ingredients that are key components of products in the personal and consumer health care, homecare and industrial sectors. The Company is the world leader in developing and producing bio-based polymers from itaconic acid, combining the versatile chemistry...